Google Antigravity enhances drug discovery with cheminformatics skills

Share

Google DeepMind demonstrated on October 15, 2026, that its Antigravity platform can link more than 30 scientific databases to accelerate life-sciences research. In one demonstration, the ProtNLM model analyzed millions of unannotated UniProt entries to identify a new antimicrobial peptide candidate. The peptide showed promising activity against Streptococcus pseudopneumoniae, was evaluated in silico with AlphaFold, and was used to produce a wet-lab experimental plan. That plan remains in the validation phase, while Antigravity can complete complex workflows in minutes instead of days and generate publication-ready outputs without requiring scientists to write code. The platform builds on Science Skills, a suite of more than 11 proteomics and cheminformatics tools introduced by Google in May 2026.

Source: Read the original article

Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
Telemac
Telemachttp://cryptoinfo.ch
Passionné de nouvelles technologies, j’explore l’univers de la blockchain et des cryptomonnaies pour partager l’actualité et les innovations du secteur.

Read More

Items